Click on image to view larger version.

Figure 3 Primary End Point: 9-Month Analysis Segment %DS

(A) Unadjusted (Unadj) and propensity score-adjusted (Adj) rates are shown for both the intention-to-treat (ITT) and per-protocol (PP) populations. The primary end point is based on the adjusted PP analysis. (B) Schematic representation of noninferiority testing results of analysis segment % diameter stenosis (%DS). The pre-specified noninferiority margin, difference (Diff) between the control and direct stent values, and upper 1-sided 95% confidence interval (CI) are presented.